» Articles » PMID: 11866440

Hyaluronan Binding Protein 1 (HABP1)/C1QBP/p32 is an Endogenous Substrate for MAP Kinase and is Translocated to the Nucleus Upon Mitogenic Stimulation

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2002 Feb 28
PMID 11866440
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The role of hyaluronan binding protein 1 (HABP1) in cell signaling was investigated and in vitro kinase assay demonstrated that it is a substrate for MAP kinase. Phosphorylation of endogenous HABP1 was also observed following treatment of J774 cells with PMA. HABP1 was coimmunoprecipitated with activated ERK, confirming their physical interaction in the cellular context. Upon PMA stimulation of normal rat fibroblast (F111) and transformed (HeLa) cells, the HABP1 level in the cytoplasm gradually decreased with a parallel increase in the nucleus. In HeLa cells, within 6 h of PMA treatment, HABP1 was completely translocated to the nucleus, which was prevented by PD98059, a selective inhibitor of ERK. We also observed that the nuclear translocation of HABP1 is concurrent with that of ERK, suggesting that ERK activation is a requirement for the translocation of HABP1. It is thus established for the first time that HABP1 is a substrate for ERK and an integral part of the MAP kinase cascade.

Citing Articles

Biomimetic Hyaluronan Binding Biomaterials to Capture the Complex Regulation of Hyaluronan in Tissue Development and Function.

Huffer A, Mao M, Ballard K, Ozdemir T Biomimetics (Basel). 2024; 9(8).

PMID: 39194478 PMC: 11351607. DOI: 10.3390/biomimetics9080499.


The Mitochondrial Protein C1QBP Promotes Hepatocellular Carcinoma Progression by Enhancing Cell Survival, Migration and Invasion.

Hou G, Lu Z, Wang Z, Yang X J Cancer. 2022; 13(8):2477-2489.

PMID: 35711850 PMC: 9174857. DOI: 10.7150/jca.69379.


An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer.

Egusquiza-Alvarez C, Robles-Flores M J Cancer Res Clin Oncol. 2022; 148(8):1831-1854.

PMID: 35441886 DOI: 10.1007/s00432-022-04001-5.


Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy.

DeSimone A, Leszyk J, Wagner K, Emerson Jr C Sci Adv. 2019; 5(12):eaaw7099.

PMID: 31844661 PMC: 6905861. DOI: 10.1126/sciadv.aaw7099.


Intracrine Endorphinergic Systems in Modulation of Myocardial Differentiation.

Canaider S, Facchin F, Tassinari R, Cavallini C, Olivi E, Taglioli V Int J Mol Sci. 2019; 20(20).

PMID: 31635381 PMC: 6829321. DOI: 10.3390/ijms20205175.